ICON Adds to Clinical, Lab Teams

ICON has made several appointments to its senior management teams in its Clinical and Central Laboratories businesses. Dr. Nuala Murphy has been appointed executive vice president, Global Clinical Operations and Data Management. Dr. Mark Roseman has been named executive vice president, Global Scientific Operations, and Dr. Era Khurana has joined ICON’s Central Laboratories’ leadership team as medical director.
 
Dr. Murphy has more than 20 years of experience in the pharmaceutical and CRO industries. She joins the company from Quintiles, where she managed clinical research professionals in Europe and Africa in her role as vice president, Clinical Operations. Dr. Murphy has expertise in therapeutics having led the CNS and internal medicine project management divisions for Quintiles. 
 
Dr. Roseman has more than 25 years of clinical research experience. Prior to ICON, he was executive vice president of Business Development at Kendle/INC. Dr. Roseman also held senior management positions in both operations and business development at PPD and supervised the oncology, cardiovascular, anti-infective, and respiratory therapeutic areas. 
 
Dr. Khurana has more than 28 years of pathology experience and joins the company from Quest Diagnostics Inc., where she was director of anatomical and clinical pathology. Dr. Khurana will provide scientific leadership and guidance and drive standards of performance and quality at ICON’s laboratories in Farmingdale, NY; Dublin, Ireland; Bangalore, India and Singapore.  
 
Ciaran Murray, chief executive officer at ICON, said, “I’m delighted to welcome Nuala, Mark and Era to the team at ICON. All three bring a wealth of operational, medical and therapeutic experience to ICON which we will leverage to support the design, planning and delivery of our clients’ drug development programs.”